Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement  of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Virtuelle Hauptversammlung ohne physische Präsenz der Aktionäre oder ihrer Bevollmächtigten on 16.05.2023 according to article 121 AktG (German St
EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2022
EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2022
EQS-News: STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR
EQS-News: STRATEC REPORTS FINAL FIGURES FOR 2022 FINANCIAL YEAR
EQS-News: SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
EQS-News: SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
EQS-News: SARTORIUS AG: Resolutions of the Annual General Meeting of Sartorius AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: Resolutions of the Annual General Meeting of Sartorius AG
EQS-News: SARTORIUS AG: Resolutions of the Annual General Meeting of Sartorius AG
Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors: https://mms.businesswire.com/media/20230321005381/en/1743191/5/Heidi_and_Hayley_Press_Release_Image.jpg
Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all

Waters stellt die nächste Generation des HPLC-Systems Alliance iS vor, das die Zahl der üblichen Laborfehler um bis zu 40 % reduzieren soll: https://mms.businesswire.com/media/20230320005171/de/1741905/5/WATERS_ALLIANCE_iS_Beauty02_LHS_Bottles_Transparent_300_dpi_ISS_A.jpg
Waters stellt die nächste Generation des HPLC-Systems Alliance iS vor, das die Zahl der üblichen Laborfehler um bis zu 40 % reduzieren soll


PITTCON 2023 Die Waters Corporation (NYSE:WAT) stellte heute mit Alliance iS ihr intelligentes HPLC-System der nächsten Generation vor. Es wurde entwickelt, um Compliance-Risiken durch neue

Die neue Battery Cycler Microcalorimeter Solution von Waters beschleunigt Praxistests von Monaten auf Wochen: https://mms.businesswire.com/media/20230320005272/de/1742096/5/TAM-Cell-Cycler-Battery_Lab-tech-loading-18650-detail.jpg
Die neue Battery Cycler Microcalorimeter Solution von Waters beschleunigt Praxistests von Monaten auf Wochen


PITTCON 2023 — Die Waters Corporation (NYSE:WAT) kündigte heute eine neue Battery Cycler Microcalorimeter Solution ihrer TA Instruments™ Division an, die eine hochauflösende Charakterisierung von

Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks: https://mms.businesswire.com/media/20230320005271/en/1742096/5/TAM-Cell-Cycler-Battery_Lab-tech-loading-18650-detail.jpg
Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks


PITTCON 2023 — Waters Corporation (NYSE:WAT) today announced a new Battery Cycler Microcalorimeter Solution from its TA Instruments™ Division for high-resolution characterization of battery cells

Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors: https://mms.businesswire.com/media/20230320005167/en/1741905/5/WATERS_ALLIANCE_iS_Beauty02_LHS_Bottles_Transparent_300_dpi_ISS_A.jpg
Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors


PITTCON 2023 Waters Corporation (NYSE:WAT) today introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error

AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)
AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)
EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise: https://mms.businesswire.com/media/20220816005068/en/1543852/5/GN_Logo_RGB_300ppi.jpg
EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise
EQS-Adhoc: GN Store Nord A/S: Update on the agenda for GN Store Nord’s Annual General Meeting and capital raise
Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast: https://mms.businesswire.com/media/20230314005483/en/1737687/5/Kelly_Ankenbrand_photo.jpg
Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast


Geisinger and Acadia Healthcare have named Kelly Ankenbrand, M.B.A., as chief executive officer for Geisinger Behavioral Health Center Northeast, a new 96-bed inpatient behavioral health hospital

LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren: https://mms.businesswire.com/media/20230309005788/de/1735168/5/Essenz_DMcDonald_Milano_2023_03_02-12.jpg
LivaNova erhält 510(k)-Freigabe der US-amerikanischen FDA für Essenz-Herz-Lungen-Maschine für kardiopulmonale Bypassverfahren


LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich medizintechnische Innovationen, gab heute bekannt, dass es die 510(k)-Freigabe von der US-amerikanischen Food and Drug

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures: https://mms.businesswire.com/media/20230309005787/en/1735168/5/Essenz_DMcDonald_Milano_2023_03_02-12.jpg
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™

EQS-Adhoc: STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-Adhoc: STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
EQS-Adhoc: STRATEC REPORTS PRELIMINARY RESULTS FOR 2022 FINANCIAL YEAR AND ISSUES FINANCIAL GUIDANCE FOR 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
Acadia Healthcare Breaks Ground on New Behavioral Health Hospital in Arizona: https://mms.businesswire.com/media/20230306005668/en/1731758/5/ACHCAgave_BH_Groundbreaking_3.6.2023.jpg
Acadia Healthcare Breaks Ground on New Behavioral Health Hospital in Arizona


Acadia Healthcare Company today held a groundbreaking ceremony marking the beginning of construction on the new hospital that the company is building to serve residents of Mesa, Arizona, and

EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft): http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
EQS-Adhoc: Fresenius SE & Co. KGaA: Outlook 2023 – Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick: https://mms.businesswire.com/media/20230216005855/en/1716502/5/Frederick_Oligo_Facility_Expansion_Rendering_2023.jpg
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick


Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent’s $725 million investment to double

EQS-News: SARTORIUS AG: The Supervisory Board of Sartorius AG proposes  a dividend of 1.44 euros per preference share : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share
EQS-News: SARTORIUS AG: The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain highhttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-News: Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation